tiprankstipranks
Lexagene Holdings (TSE:LXG)
TSXV:LXG

Lexagene Holdings Stock Price & Analysis

36 Followers

LXG Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.11 - C$0.59
Previous CloseC$0.13
Volume17.16K
Average Volume (3M)36.89K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)C$1.72M
Total Debt (Recent Filing)C$1.10M
P/E Ratio-1.3
Beta0.04
Next EarningsJul 25, 2022
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-0.10
Shares Outstanding138,730,373
R-Squared0.08
Standard Deviation0.23
10 Day Avg. Volume36,179
30 Day Avg. Volume36,893
P/B Ratio3.14
P/S Ratio272.64
P/CF RatioN/A
P/FCF Ratio-2.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.01
Number of Analyst Covering0


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

LXG FAQ

What was Lexagene Holdings’s price range in the past 12 months?
Lexagene Holdings lowest stock price was C$0.10 and its highest was C$0.59 in the past 12 months.
    What is Lexagene Holdings’s market cap?
    Currently, no data Available
    When is Lexagene Holdings’s upcoming earnings report date?
    Lexagene Holdings’s upcoming earnings report date is Jul 25, 2022 which is 71 days ago.
      How were Lexagene Holdings’s earnings last quarter?
      Lexagene Holdings released its earnings results on Jan 31, 2022. The company reported -C$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.029.
        Is Lexagene Holdings overvalued?
        According to Wall Street analysts Lexagene Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Lexagene Holdings pay dividends?
          Lexagene Holdings does not currently pay dividends.
          What is Lexagene Holdings’s EPS estimate?
          Lexagene Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Lexagene Holdings have?
          Lexagene Holdings has 138,730,380 shares outstanding.
            What happened to Lexagene Holdings’s price movement after its last earnings report?
            Lexagene Holdings reported an EPS of -C$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Lexagene Holdings?
              Currently, no hedge funds are holding shares in TSE:LXG

              ---

              Lexagene Holdings Stock Analysis

              Smart ScoreNot Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              N/A

              Analyst Consensus

              N/A
              Currently Not Enough Data Available

              Blogger Sentiment

              N/A
              Currently Not Enough Data Available

              Hedge Fund Holdings

              N/A
              Currently Not Enough Data Available

              Insider Transactions

              N/A
              Currently Not Enough Data Available

              Retail Investors

              N/A
              Currently Not Enough Data Available

              News Sentiment

              N/A
              Currently Not Enough Data Available

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -71.23%
              12-Months-Change

              Fundamentals

              Return on Equity
              -159.55%
              Trailing 12-Months
              Asset Growth
              -38.76%
              Trailing 12-Months
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Lexagene Holdings

              Lexagene Holdings Inc is a biotechnology company. The principal business of the company is to research, develop and commercialize pathogen detection devices in the biochemical industry. The firm operates in one segment namely Development of genetic analyzers.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              K2 Gold
              Opus One Resources Inc
              Twyford Ventures
              Xander Resources
              Venerable Ventures

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis